ID   ACS2A_HUMAN             Reviewed;         577 AA.
AC   Q08AH3; B3KTT9; O75202;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 2.
DT   15-MAR-2017, entry version 88.
DE   RecName: Full=Acyl-coenzyme A synthetase ACSM2A, mitochondrial;
DE            EC=6.2.1.2;
DE   AltName: Full=Acyl-CoA synthetase medium-chain family member 2A;
DE   AltName: Full=Butyrate--CoA ligase 2A;
DE   AltName: Full=Butyryl-coenzyme A synthetase 2A;
DE   AltName: Full=Middle-chain acyl-CoA synthetase 2A;
DE   Flags: Precursor;
GN   Name=ACSM2A; Synonyms=ACSM2, MACS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 299-577, AND VARIANT
RP   LEU-513.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH AMP AND
RP   MAGNESIUM.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of L64P mutant of human acyl-CoA synthetase medium-
RT   chain family member 2A.";
RL   Submitted (FEB-2008) to the PDB data bank.
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 32-577 IN COMPLEXES WITH ATP;
RP   COENZYME A; IBUPROFEN AND MAGNESIUM.
RX   PubMed=19345228; DOI=10.1016/j.jmb.2009.03.064;
RA   Kochan G., Pilka E.S., von Delft F., Oppermann U., Yue W.W.;
RT   "Structural snapshots for the conformation-dependent catalysis by
RT   human medium-chain acyl-coenzyme A synthetase ACSM2A.";
RL   J. Mol. Biol. 388:997-1008(2009).
RN   [8]
RP   VARIANT LEU-513.
RX   PubMed=12654705; DOI=10.1161/01.HYP.0000064944.60569.87;
RA   Iwai N., Mannami T., Tomoike H., Ono K., Iwanaga Y.;
RT   "An acyl-CoA synthetase gene family in chromosome 16p12 may contribute
RT   to multiple risk factors.";
RL   Hypertension 41:1041-1046(2003).
RN   [9]
RP   VARIANT LEU-513.
RX   PubMed=16521160; DOI=10.1002/mnfr.200500241;
RA   Lindner I., Rubin D., Helwig U., Nitz I., Hampe J., Schreiber S.,
RA   Schrezenmeir J., Doering F.;
RT   "The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2)
RT   is associated with risk factors of the metabolic syndrome in a
RT   Caucasian study population.";
RL   Mol. Nutr. Food Res. 50:270-274(2006).
CC   -!- FUNCTION: Has medium-chain fatty acid:CoA ligase activity with
CC       broad substrate specificity (in vitro). Acts on acids from C(4) to
CC       C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4-
CC       unsaturated acids (in vitro) (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a carboxylate + CoA = AMP + diphosphate
CC       + an acyl-CoA.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:19345228, ECO:0000269|Ref.6};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:19345228, ECO:0000269|Ref.6};
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC23497.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096039; BAG53201.1; -; mRNA.
DR   EMBL; AC137056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC125176; AAI25177.1; -; mRNA.
DR   EMBL; AC003034; AAC23497.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS32401.1; -.
DR   RefSeq; NP_001295101.1; NM_001308172.1.
DR   RefSeq; NP_001295883.1; NM_001308954.1.
DR   RefSeq; XP_016878412.1; XM_017022923.1.
DR   UniGene; Hs.298252; -.
DR   UniGene; Hs.656497; -.
DR   PDB; 2VZE; X-ray; 2.45 A; A/B/C=32-577.
DR   PDB; 2WD9; X-ray; 2.60 A; A/B/C=32-576.
DR   PDB; 3B7W; X-ray; 2.00 A; A=32-577.
DR   PDB; 3C5E; X-ray; 1.60 A; A=32-577.
DR   PDB; 3DAY; X-ray; 1.95 A; A=32-577.
DR   PDB; 3EQ6; X-ray; 2.40 A; A/B=32-577.
DR   PDB; 3GPC; X-ray; 1.90 A; A/B=32-577.
DR   PDBsum; 2VZE; -.
DR   PDBsum; 2WD9; -.
DR   PDBsum; 3B7W; -.
DR   PDBsum; 3C5E; -.
DR   PDBsum; 3DAY; -.
DR   PDBsum; 3EQ6; -.
DR   PDBsum; 3GPC; -.
DR   ProteinModelPortal; Q08AH3; -.
DR   SMR; Q08AH3; -.
DR   STRING; 9606.ENSP00000219054; -.
DR   iPTMnet; Q08AH3; -.
DR   PhosphoSitePlus; Q08AH3; -.
DR   BioMuta; ACSM2A; -.
DR   DMDM; 257050995; -.
DR   MaxQB; Q08AH3; -.
DR   PaxDb; Q08AH3; -.
DR   PeptideAtlas; Q08AH3; -.
DR   PRIDE; Q08AH3; -.
DR   Ensembl; ENST00000219054; ENSP00000219054; ENSG00000183747.
DR   Ensembl; ENST00000396104; ENSP00000379411; ENSG00000183747.
DR   Ensembl; ENST00000573854; ENSP00000459451; ENSG00000183747.
DR   Ensembl; ENST00000575690; ENSP00000460349; ENSG00000183747.
DR   GeneID; 123876; -.
DR   KEGG; hsa:123876; -.
DR   UCSC; uc002dhf.5; human.
DR   CTD; 123876; -.
DR   DisGeNET; 123876; -.
DR   GeneCards; ACSM2A; -.
DR   H-InvDB; HIX0012859; -.
DR   HGNC; HGNC:32017; ACSM2A.
DR   HPA; HPA057699; -.
DR   MIM; 614358; gene.
DR   neXtProt; NX_Q08AH3; -.
DR   OpenTargets; ENSG00000183747; -.
DR   PharmGKB; PA162375402; -.
DR   eggNOG; KOG1175; Eukaryota.
DR   eggNOG; COG0365; LUCA.
DR   GeneTree; ENSGT00760000119178; -.
DR   HOGENOM; HOG000229982; -.
DR   HOVERGEN; HBG053031; -.
DR   InParanoid; Q08AH3; -.
DR   KO; K01896; -.
DR   OMA; VIDHWAG; -.
DR   OrthoDB; EOG091G03NW; -.
DR   PhylomeDB; Q08AH3; -.
DR   TreeFam; TF354264; -.
DR   Reactome; R-HSA-177128; Conjugation of salicylate with glycine.
DR   EvolutionaryTrace; Q08AH3; -.
DR   GenomeRNAi; 123876; -.
DR   PRO; PR:Q08AH3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000183747; -.
DR   ExpressionAtlas; Q08AH3; baseline and differential.
DR   Genevisible; Q08AH3; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; NAS:BHF-UCL.
DR   GO; GO:0003996; F:acyl-CoA ligase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047760; F:butyrate-CoA ligase activity; IDA:BHF-UCL.
DR   GO; GO:0015645; F:fatty acid ligase activity; IBA:GO_Central.
DR   GO; GO:0004321; F:fatty-acyl-CoA synthase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0042593; P:glucose homeostasis; NAS:BHF-UCL.
DR   GO; GO:0036112; P:medium-chain fatty-acyl-CoA metabolic process; IDA:BHF-UCL.
DR   GO; GO:0070328; P:triglyceride homeostasis; NAS:BHF-UCL.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome;
KW   Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium;
KW   Metal-binding; Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     46       Mitochondrion. {ECO:0000255}.
FT   CHAIN        47    577       Acyl-coenzyme A synthetase ACSM2A,
FT                                mitochondrial.
FT                                /FTId=PRO_0000306093.
FT   NP_BIND     221    229       ATP. {ECO:0000269|PubMed:19345228,
FT                                ECO:0000269|Ref.6}.
FT   NP_BIND     359    364       ATP. {ECO:0000269|PubMed:19345228,
FT                                ECO:0000269|Ref.6}.
FT   REGION      469    471       Coenzyme A binding.
FT                                {ECO:0000269|PubMed:19345228}.
FT   REGION      540    542       Coenzyme A binding.
FT                                {ECO:0000269|PubMed:19345228}.
FT   BINDING     139    139       Coenzyme A.
FT                                {ECO:0000269|PubMed:19345228}.
FT   BINDING     364    364       Substrate. {ECO:0000269|PubMed:19345228}.
FT   BINDING     446    446       ATP. {ECO:0000269|PubMed:19345228,
FT                                ECO:0000269|Ref.6}.
FT   BINDING     461    461       ATP. {ECO:0000269|PubMed:19345228,
FT                                ECO:0000269|Ref.6}.
FT   BINDING     472    472       Substrate. {ECO:0000269|PubMed:19345228}.
FT   BINDING     501    501       Coenzyme A.
FT                                {ECO:0000269|PubMed:19345228}.
FT   BINDING     532    532       Coenzyme A.
FT                                {ECO:0000269|PubMed:19345228}.
FT   BINDING     557    557       ATP. {ECO:0000269|PubMed:19345228,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     141    141       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   MOD_RES     141    141       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   MOD_RES     327    327       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BGA8}.
FT   MOD_RES     513    513       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68CK6}.
FT   MOD_RES     525    525       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   MOD_RES     532    532       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   MOD_RES     532    532       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   MOD_RES     543    543       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q91VA0}.
FT   VARIANT     335    335       V -> L (in dbSNP:rs4643305).
FT                                /FTId=VAR_058692.
FT   VARIANT     336    336       T -> A (in dbSNP:rs5002299).
FT                                /FTId=VAR_058693.
FT   VARIANT     337    337       V -> G (in dbSNP:rs4586421).
FT                                /FTId=VAR_058694.
FT   VARIANT     513    513       S -> L (in dbSNP:rs1133607).
FT                                {ECO:0000269|PubMed:10493829,
FT                                ECO:0000269|PubMed:12654705,
FT                                ECO:0000269|PubMed:16521160}.
FT                                /FTId=VAR_035247.
FT   VARIANT     561    561       A -> T (in dbSNP:rs1054977).
FT                                /FTId=VAR_035248.
FT   CONFLICT    463    463       N -> D (in Ref. 1; BAG53201, 3; AAI25177
FT                                and 4; AAC23497). {ECO:0000305}.
FT   TURN         34     36       {ECO:0000244|PDB:3B7W}.
FT   HELIX        46     49       {ECO:0000244|PDB:3C5E}.
FT   HELIX        51     59       {ECO:0000244|PDB:3C5E}.
FT   STRAND       67     72       {ECO:0000244|PDB:3C5E}.
FT   STRAND       74     76       {ECO:0000244|PDB:3C5E}.
FT   STRAND       78     82       {ECO:0000244|PDB:3C5E}.
FT   HELIX        83     98       {ECO:0000244|PDB:3C5E}.
FT   TURN         99    101       {ECO:0000244|PDB:3C5E}.
FT   STRAND      108    112       {ECO:0000244|PDB:3C5E}.
FT   HELIX       117    129       {ECO:0000244|PDB:3C5E}.
FT   STRAND      132    135       {ECO:0000244|PDB:3C5E}.
FT   HELIX       142    152       {ECO:0000244|PDB:3C5E}.
FT   STRAND      155    160       {ECO:0000244|PDB:3C5E}.
FT   TURN        161    163       {ECO:0000244|PDB:3C5E}.
FT   HELIX       164    170       {ECO:0000244|PDB:3C5E}.
FT   HELIX       171    173       {ECO:0000244|PDB:3C5E}.
FT   STRAND      179    186       {ECO:0000244|PDB:3C5E}.
FT   STRAND      191    193       {ECO:0000244|PDB:3C5E}.
FT   HELIX       194    200       {ECO:0000244|PDB:3C5E}.
FT   STRAND      214    220       {ECO:0000244|PDB:3C5E}.
FT   STRAND      224    227       {ECO:0000244|PDB:3C5E}.
FT   STRAND      230    234       {ECO:0000244|PDB:3C5E}.
FT   HELIX       235    245       {ECO:0000244|PDB:3C5E}.
FT   TURN        246    249       {ECO:0000244|PDB:3C5E}.
FT   STRAND      256    259       {ECO:0000244|PDB:3C5E}.
FT   HELIX       266    271       {ECO:0000244|PDB:3C5E}.
FT   HELIX       274    278       {ECO:0000244|PDB:3C5E}.
FT   STRAND      282    286       {ECO:0000244|PDB:3C5E}.
FT   HELIX       293    302       {ECO:0000244|PDB:3C5E}.
FT   STRAND      307    310       {ECO:0000244|PDB:3C5E}.
FT   HELIX       312    319       {ECO:0000244|PDB:3C5E}.
FT   TURN        323    325       {ECO:0000244|PDB:3C5E}.
FT   STRAND      333    339       {ECO:0000244|PDB:3C5E}.
FT   HELIX       343    353       {ECO:0000244|PDB:3C5E}.
FT   STRAND      358    363       {ECO:0000244|PDB:3C5E}.
FT   TURN        364    366       {ECO:0000244|PDB:3C5E}.
FT   STRAND      367    371       {ECO:0000244|PDB:3C5E}.
FT   STRAND      392    395       {ECO:0000244|PDB:3C5E}.
FT   STRAND      408    413       {ECO:0000244|PDB:3C5E}.
FT   STRAND      415    417       {ECO:0000244|PDB:3C5E}.
FT   HELIX       430    435       {ECO:0000244|PDB:3C5E}.
FT   STRAND      441    450       {ECO:0000244|PDB:3C5E}.
FT   STRAND      456    461       {ECO:0000244|PDB:3C5E}.
FT   HELIX       462    464       {ECO:0000244|PDB:3C5E}.
FT   STRAND      466    468       {ECO:0000244|PDB:3C5E}.
FT   STRAND      471    473       {ECO:0000244|PDB:3C5E}.
FT   HELIX       475    483       {ECO:0000244|PDB:3C5E}.
FT   STRAND      488    498       {ECO:0000244|PDB:3C5E}.
FT   TURN        499    501       {ECO:0000244|PDB:3C5E}.
FT   STRAND      502    511       {ECO:0000244|PDB:3C5E}.
FT   HELIX       513    515       {ECO:0000244|PDB:3C5E}.
FT   HELIX       520    534       {ECO:0000244|PDB:3C5E}.
FT   HELIX       537    539       {ECO:0000244|PDB:3C5E}.
FT   STRAND      542    548       {ECO:0000244|PDB:3C5E}.
FT   HELIX       560    567       {ECO:0000244|PDB:3C5E}.
SQ   SEQUENCE   577 AA;  64223 MW;  16167FC69562436F CRC64;
     MHWLRKVQGL CTLWGTQMSS RTLYINSRQL VSLQWGHQEV PAKFNFASDV LDHWADMEKA
     GKRLPSPALW WVNGKGKELM WNFRELSENS QQAANVLSGA CGLQRGDRVA VVLPRVPEWW
     LVILGCIRAG LIFMPGTIQM KSTDILYRLQ MSKAKAIVAG DEVIQEVDTV ASECPSLRIK
     LLVSEKSCDG WLNFKKLLNE ASTTHHCVET GSQEASAIYF TSGTSGLPKM AEHSYSSLGL
     KAKMDAGWTG LQASDIMWTI SDTGWILNIL CSLMEPWALG ACTFVHLLPK FDPLVILKTL
     SSYPIKSMMG APIVYRMLLQ QDLSSYKFPH LQNCVTVGES LLPETLENWR AQTGLDIRES
     YGQTETGLTC MVSKTMKIKP GYMGTAASCY DVQIIDDKGN VLPPGTEGDI GIRVKPIRPI
     GIFSGYVDNP DKTAANIRGD FWLLGDRGIK DEDGYFQFMG RANDIINSSG YRIGPSEVEN
     ALMEHPAVVE TAVISSPDPV RGEVVKAFVV LASQFLSHDP EQLTKELQQH VKSVTAPYKY
     PRKIEFVLNL PKTVTGKIQR AKLRDKEWKM SGKARAQ
//
